Cargando…
Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies
The promise of tumor immunotherapy to significantly improve survival in patients who are refractory to long-standing therapies, such as chemotherapy and radiation, is now being realized. While immune checkpoint inhibitors that target PD-1 and CTLA-4 are leading the charge in clinical efficacy, there...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081050/ https://www.ncbi.nlm.nih.gov/pubmed/33936058 http://dx.doi.org/10.3389/fimmu.2021.642316 |